Partners

In 2025, SAFE-ID receives unrestricted educational grants for the annual programme from the following partners:

 

Founding partner

 

GlaxoSmithKline AG

 

Associate partner

 

ViiV Healthcare GmbH

 

 




Event partners

 

Financial support 2025

  • GSK: 30'000 CHF
  • ViiV Healthcare: 75'000 CHF
  • Gilead: 50'000 CHF
  • MSD: 50'000 CHF
  • Menarini: 5'000 CHF

All partners contribute to all educational events organised by SAFE-ID

 

Event Partner Menarini is supporting all Virtual Lunch sessions.